|
Re: Renal trial delayed (again)
|
4
|
Resverlogix Corp.
|
Sep 28, 2017 02:21AM
|
|
Re: Resverlogix Publications, Presentations and Abstracts
|
2
|
Resverlogix Corp.
|
Sep 27, 2017 10:19AM
|
|
Re: ReCvr
|
2
|
Resverlogix Corp.
|
Sep 25, 2017 02:58PM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
5
|
Resverlogix Corp.
|
Sep 25, 2017 01:38PM
|
|
Re: Demoralizing....
|
3
|
Resverlogix Corp.
|
Sep 22, 2017 05:33PM
|
|
Re: Demoralizing....
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 02:25PM
|
|
Re: Resverlogix now listed as a Presenting Company at Biopharm America
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 02:16PM
|
|
Re: Resverlogix now listed as a Presenting Company at Biopharm America
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 11:34AM
|
|
Re: Demoralizing....
|
1
|
Resverlogix Corp.
|
Sep 22, 2017 11:24AM
|
|
Re: Demoralizing....
|
1
|
Resverlogix Corp.
|
Sep 22, 2017 11:11AM
|
|
Re: Demoralizing....
|
3
|
Resverlogix Corp.
|
Sep 22, 2017 01:36AM
|
|
Re: Has Kenneth Lebioda done presentations before?
|
4
|
Resverlogix Corp.
|
Sep 22, 2017 01:32AM
|
|
Re: Short interest climbs to 185,900
|
2
|
Resverlogix Corp.
|
Sep 21, 2017 01:48PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Sep 21, 2017 03:57AM
|
|
Re: Short interest climbs to 185,900
|
1
|
Resverlogix Corp.
|
Sep 21, 2017 03:32AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Sep 19, 2017 01:04PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
6
|
Resverlogix Corp.
|
Sep 19, 2017 12:26AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Sep 18, 2017 11:17PM
|
|
Random thoughts - missed presentations/confer...
|
6
|
Resverlogix Corp.
|
Sep 18, 2017 12:35PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
4
|
Resverlogix Corp.
|
Sep 17, 2017 10:37AM
|
